food
and
drug
administration
[
docket
no
.
94n0013
]
<
doctitledrug
export
;
ubi
&
reg
;
hiv
1/2
pha/doctitle
>
<
agency
>
agency
:
food
and
drug
administration
,
hhs
.
<
agency
>
<
action
>
action
:
notice
.
<
action
>
<
summary
>
summary
:
the
food
and
drug
administration
(
fda
)
is
announcing
that
united
biomedical
,
inc
,
has
filed
an
application
requesting
approval
for
the
export
of
the
human
biological
product
ubi
&
reg
;
hiv
1/2
pha
(
passive
hemagglutination
assay
)
to
belgium
,
the
netherlands
,
sweden
,
and
the
united
kingdom
.
<
summary
>
<
address
>
addresses
:
relevant
information
on
this
application
may
be
directed
to
the
dockets
management
branch
(
hfa305
hfa
,
food
and
drug
administration
,
rm
.
123
,
12420
parklawn
dr
,
rockville
,
md
20857
,
and
to
the
contact
person
identified
below
.
any
future
inquiries
concerning
the
export
of
human
biological
products
under
the
drug
export
amendments
act
of
1986
should
also
be
directed
to
the
contact
person
.
<
address
>
<
further
>
for
further
information
contact
:
frederick
w
.
blumenschein
,
center
for
biologics
evaluation
and
research
(
hfm660
hfm
,
food
and
drug
administration
,
1401
rockville
pike
,
rockville
,
md
208521448
,
3015941070
.
<
further
>
<
supplem
>
supplementary
information
:
the
drug
export
provisions
in
section
802
of
the
federal
food
,
drug
,
and
cosmetic
act
(
the
act
)
(
21
usc
.
382
)
provide
that
fda
may
approve
applications
for
the
export
of
human
biological
products
that
are
not
currently
approved
in
the
united
states
.
section
802b3b
)
of
the
act
sets
forth
the
requirements
that
must
be
met
in
an
application
for
approval
.
section
802b3c
)
of
the
act
requires
that
the
agency
review
the
application
within
30
days
of
its
filing
to
determine
whether
the
requirements
of
section
802b3b
)
have
been
satisfied
.
section
802b3a
)
of
the
act
requires
that
the
agency
publish
a
notice
in
the
federal
register
within
10
days
of
the
filing
of
an
application
for
export
to
facilitate
public
participation
in
its
review
of
the
application
.
to
meet
this
requirement
,
the
agency
is
providing
notice
that
united
biomedical
,
inc
,
25
davids
dr
,
hauppauge
,
ny
11788
,
has
filed
an
application
requesting
approval
for
the
export
of
the
human
biological
product
ubi
&
reg
;
hiv
1/2
pha
to
belgium
,
the
netherlands
,
sweden
,
and
the
united
kingdom
.
the
ubi
&
reg
;
hiv
1/2
pha
is
an
in
vitro
qualitative
,
passive
hemagglutination
assay
test
for
the
detection
of
human
immunodeficiency
virus
(
hiv1
hiv
and
hiv2
hiv
)
antibodies
in
serum
or
plasma
.
the
application
was
received
and
filed
in
the
center
for
biologics
evaluation
and
research
on
10/26/1993
,
which
shall
be
considered
the
filing
date
for
purposes
of
the
act
.
interested
persons
may
submit
relevant
information
on
the
application
to
the
dockets
management
branch
(
address
above
)
in
two
copies
(
except
that
individuals
may
submit
single
copies
)
and
identified
with
the
docket
number
found
in
brackets
in
the
heading
of
this
document
.
these
submissions
may
be
seen
in
the
dockets
management
branch
between
9
am
.
and
4
pm
,
monday
through
friday
.
the
agency
encourages
any
person
who
submits
relevant
information
on
the
application
to
do
so
by
02/07/1994
,
and
to
provide
an
additional
copy
of
the
submission
directly
to
the
contact
person
identified
above
,
to
facilitate
consideration
of
the
information
during
the
30day
day
review
period
.
this
notice
is
issued
under
the
federal
food
,
drug
,
and
cosmetic
act
(
sec
.
802
(
21
usc
.
382
)
and
under
authority
delegated
to
the
commissioner
of
food
and
drugs
(
21
cfr
5
10
)
and
redelegated
to
the
center
for
biologics
evaluation
and
research
(
21
cfr
5
44
.
dated
:
01/18/1994
.
<
supplem
>
<
signer
>
p
.
michael
dubinsky
,
<
signer
>
<
signjob
>
acting
director
,
office
of
compliance
,
center
for
biologics
evaluation
and
research
.
<
signjob
>
<
frfiling
>
[
fr
doc
.
941794
filed
01/27/1994
;
845
am
]
<
frfiling
>
<
billing
>
billing
code
416001f
<
billing
>
<
text
>
